<?xml version="1.0" encoding="UTF-8"?>
<p>In this study, it was established that diabetic untreated group (Figures 
 <xref ref-type="fig" rid="fig1">1</xref>
 <xref ref-type="fig" rid="fig2"/>–
 <xref ref-type="fig" rid="fig3">3</xref>) showed a statistically significant decrease (
 <italic>p</italic> &lt; 0.05) in CAT (10.8 ± 0.6 u/mg), SOD (12.8 ± 0.2 u/mg), and GPx (0.48 ± 0.6 nmol/mg) activities compared to normal rats without treatment. Diabetic rats treated with 
 <italic>A. conyzoides</italic> significantly increased (
 <italic>p</italic> &lt; 0.05) in cardiac CAT (36.4 ± 1.1 to 38.2 ± 1.3 u/mg), SOD (38.2 ± 1.2 to 40.8 ± 1.4 u/mg), and GPx (0.96 ± 0.5 to 0.97 ± 0.4 nmol/mg) activities (Figures 
 <xref ref-type="fig" rid="fig1">1</xref>
 <xref ref-type="fig" rid="fig2"/>–
 <xref ref-type="fig" rid="fig3">3</xref>) compared to the diabetic untreated animals, along the same line. However, a significant decrease (
 <italic>p</italic> &lt; 0.05) in MDA content (4.4 ± 0.6 nmol/mg) (
 <xref ref-type="fig" rid="fig4">Figure 4</xref>) was observed in the diabetic untreated group when compared to the normal animals. Diabetic treated group with the 
 <italic>A. conyzoides</italic>, however, significantly reduced the MDA (1.48 ± 0.2 to 1.47 ± 0.4 nmol/mg) (
 <xref ref-type="fig" rid="fig4">Figure 4</xref>) compared to the diabetic group.
</p>
